Monthly
US$200
Billed every month
Sign in to subscribeDoxofylline Injection
As of 13 November 2026, for Doxofylline Injection, 5 applications are listed as under review at China's CDE; 2 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 39 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 2 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders39View records ↓
Under-review filings5View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers62View records ↓
API companies with A status23View records ↓
Chemical-drug catalogue
Loaded records: 39 holders; 10 in the quality-and-efficacy consistency-evaluation category, and 29 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Henan Pu Rui Pharma Co., Ltd. romanized | Henan Pu Rui Pharma Co., Ltd. romanized | 国药准字H20265518 | 2026/08/04 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20269032 | 2026/02/11 | 20ml:0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Yunnan Yao Ke Yuan Biopharmaceuticals Co., Ltd. romanized | Chu Xiong He Chuang Pharma Co., Ltd. romanized | 国药准字H20255789 | 2025/10/28 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20258160 | 2025/08/13 | 20ml：0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Hubei Wu Shi Pharmaceuticals Research Institute Co., Ltd. romanized | Hubei Wu Shi Pharma Co., Ltd. romanized | 国药准字H20253668 | 2025/03/18 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang Innovation Bio Co., Ltd. romanized | 国药准字H20253360 | 2025/02/08 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Yi Jian Pharma Co., Ltd. romanized | Shandong Yi Jian Pharma Co., Ltd. romanized | 国药准字H20253302 | 2025/01/24 | 10ml:0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Ming Sheng Kang Yuan Pharma Co., Ltd. romanized | Jiangsu Jiu Xu Pharma Co., Ltd. romanized | 国药准字H20244712 | 2024/08/20 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20244561 | 2024/07/30 | 10ml：0.1g | Not stated by source | CDE |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20244562 | 2024/07/30 | 20ml：0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Hubei Mei Lin Pharma Co., Ltd. romanized | Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20244081 | 2024/06/18 | 20ml:0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Hubei Mei Lin Pharma Co., Ltd. romanized | Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20244080 | 2024/06/18 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | 国药准字H20243777 | 2024/05/21 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Chi Feng Wan Ze Pharma Co., Ltd. romanized | Hebei Tian Cheng Pharma Co., Ltd. romanized | 国药准字H20243638 | 2024/04/30 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Kai Wei Heng Cheng Pharmaceutical Co., Ltd. romanized | Hebei Kai Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20243618 | 2024/04/24 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20243015 | 2024/01/09 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20234452 | 2023/10/30 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized | Chengdu Bai Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20183230 | 2023/07/17 | 10ml:0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shandong Qidu Pharmaceutical Co., Ltd. | Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20233433 | 2023/04/11 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Zhen Ao Pharmaceutical Co., Ltd. romanized | Jilin Zhen Ao Pharmaceutical Co., Ltd. romanized | 国药准字H20233215 | 2023/02/21 | 10ml:0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei Kang Nuo Biopharmaceutical Co., Ltd. romanized | Kai Feng Kang Nuo Pharma Co., Ltd. romanized | 国药准字H20233192 | 2023/02/14 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223911 | 2022/11/30 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Hua Lu Pharmaceutical Co., Ltd. romanized | Shandong Hua Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20223865 | 2022/11/22 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Guangxi Ming Lei Wei Sheng Pharmaceutical Co., Ltd. romanized | Guangxi Ming Lei Wei Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20223695 | 2022/09/30 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20227105 | 2022/08/18 | 20ml:0.2g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20223576 | 2022/08/10 | 20ml：0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Bai Mei Te Biopharmaceutical Co., Ltd. romanized | Beijing Bai Mei Te Biopharmaceutical Co., Ltd. romanized | 国药准字H20223521 | 2022/07/19 | 10ml:0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20223300 | 2022/05/10 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | 国药准字H20213992 | 2021/12/31 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Fu An Pharma Group Yan Tai Zhi Chu Pharma Co., Ltd. romanized | Fu An Pharma Group Yan Tai Zhi Chu Pharma Co., Ltd. romanized | 国药准字H20213990 | 2021/12/31 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20217134 | 2021/12/11 | 20ml:0.2g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | Hebei Kai Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20213877 | 2021/11/17 | 10ml:0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Yunnan Long Hai Tian Ran Zhi Wu Pharma Co., Ltd. romanized | Yunnan Long Hai Tian Ran Zhi Wu Pharma Co., Ltd. romanized | 国药准字H20213518 | 2021/06/18 | 10ml : 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Rui Yang Pharmaceutical Co., Ltd. romanized | Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183013 | 2021/06/16 | 10ml:0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20041759 | 2021/06/09 | 10ml:0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Wei Sheng Yuan (Xiamen) Bio Technology Co., Ltd. romanized | Fuzhou Hai Wang Fu Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20213430/2021S00559 | 2021/06/01 | 10ml：0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | 国药准字H20000304 | 2021/05/25 | 10ml：0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | 国药准字H20083883 | 2021/05/25 | 20ml：0.2g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | 国药准字H20183135 | 2021/04/29 | 10ml:0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hua Yuan Pharma Co., Ltd. romanized | Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20193088 | 2021/01/22 | 10ml:0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20123351 | 2020/12/31 | 10 ml:0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Shanxi Nuo Cheng Pharmaceutical Co., Ltd. romanized | Shanxi Nuo Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H20183188 | 2020/12/31 | 10ml:0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20133217 | 2020/12/24 | 20ml:0.2g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20040617 | 2020/12/24 | 10ml:0.1g | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H20203304 | 2020/07/08 | 10ml:0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203015 | 2020/01/21 | 10ml:0.1g | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 62 distinct approval numbers and 43 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| YaoPharma Co., Ltd. | 国药准字H20183214 | 10ml:0.1g | Category B | XR03DAD179B002010101066 | NHSA |
| Changzhou Lan Ling Pharmaceutical Co., Ltd. romanized | 国药准字H20103810 | 10ml:0.1g | Category B | XR03DAD179B002010101376 | NHSA |
| Nanjing Chen Gong Pharmaceutical Co., Ltd. romanized | 国药准字H20093474 | 10ml:0.1g | Category B | XR03DAD179B002010101556 | NHSA |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H20203304 | 10ml:0.1g | Category B | XR03DAD179B002010101748 | NHSA |
| Sichuan Yi Sheng Zhi Tong Pharmaceuticals Bio Technology Development Co., Ltd. romanized | 国药准字H20213992 | 10ml:0.1g | Category B | XR03DAD179B002010102087 | NHSA |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20244561 | 10ml:0.1g | Category B | XR03DAD179B002010102357 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203015 | 10ml:0.1g | Category B | XR03DAD179B002010102763 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20223300 | 10ml:0.1g | Category B | XR03DAD179B002010102770 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20213877 | 10ml:0.1g | Category B | XR03DAD179B002010102829 | NHSA |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223911 | 10ml:0.1g | Category B | XR03DAD179B002010103516 | NHSA |
| Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | 国药准字H20000304 | 10ml:0.1g | Category B | XR03DAD179B002010103731 | NHSA |
| Chi Feng Wan Ze Pharma Co., Ltd. romanized | 国药准字H20243638 | 10ml:0.1g | Category B | XR03DAD179B002010103869 | NHSA |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | 国药准字H20243777 | 10ml:0.1g | Category B | XR03DAD179B002010104131 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20233433 | 10ml:0.1g | Category B | XR03DAD179B002010104145 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183013 | 10ml:0.1g | Category B | XR03DAD179B002010104152 | NHSA |
| Shandong Yi Jian Pharma Co., Ltd. romanized | 国药准字H20253302 | 10ml:0.1g | Category B | XR03DAD179B002010104192 | NHSA |
| Fu An Pharma Group Yan Tai Zhi Chu Pharma Co., Ltd. romanized | 国药准字H20213990 | 10ml:0.1g | Category B | XR03DAD179B002010104251 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20243015 | 10ml:0.1g | Category B | XR03DAD179B002010104383 | NHSA |
| Hainan Wei Kang Pharmaceutical (Qian Shan) Co., Ltd. romanized | 国药准字H20143049 | 10ml:0.2g | Category B | XR03DAD179B002010104384 | NHSA |
| Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20041759 | 10ml:0.1g | Category B | XR03DAD179B002010104561 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20253360 | 10ml:0.1g | Category B | XR03DAD179B002010104606 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20040617 | 10ml:0.1g | Category B | XR03DAD179B002010104610 | NHSA |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20193088 | 10ml:0.1g | Category B | XR03DAD179B002010104646 | NHSA |
| Wei Sheng Yuan (Xiamen) Bio Technology Co., Ltd. romanized | 国药准字H20213430 | 10ml:0.1g | Category B | XR03DAD179B002010104827 | NHSA |
| Shanxi Nuo Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H20183188 | 10ml:0.1g | Category B | XR03DAD179B002010105619 | NHSA |
| Zhejiang Hai Han Pharma Co., Ltd. romanized | 国药准字H20213518 | 10ml:0.1g | Category B | XR03DAD179B002010106286 | NHSA |
| Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized | 国药准字H20183230 | 10ml:0.1g | Category B | XR03DAD179B002010106725 | NHSA |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20123351 | 10ml:0.1g | Category B | XR03DAD179B002010107478 | NHSA |
| Jilin Zhen Ao Pharmaceutical Co., Ltd. romanized | 国药准字H20233215 | 10ml:0.1g | Category B | XR03DAD179B002010109876 | NHSA |
| ABC Farmaceutici SPA | 国药准字HJ20170323 | 10ml:0.1g | Category B | XR03DAD179B002010179568 | NHSA |
| Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | 国药准字H20183135 | 10ml:0.1g | Category B | XR03DAD179B002010181128 | NHSA |
| Beijing Bai Mei Te Biopharmaceutical Co., Ltd. romanized | 国药准字H20223521 | 10ml:0.1g | Category B | XR03DAD179B002010182359 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20244080 | 10ml:0.1g | Category B | XR03DAD179B002010182474 | NHSA |
| Guangxi Ming Lei Wei Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20223695 | 10ml:0.1g | Category B | XR03DAD179B002010182886 | NHSA |
| Hebei Kai Wei Heng Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243618 | 10ml:0.1g | Category B | XR03DAD179B002010183007 | NHSA |
| Shandong Hua Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20223865 | 10ml:0.1g | Category B | XR03DAD179B002010183083 | NHSA |
| Kang Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20233192 | 10ml:0.1g | Category B | XR03DAD179B002010183596 | NHSA |
| Name not romanized | 国药准字H20258160 | 20ml:0.2g | Category B | XR03DAD179B002010184294 | NHSA |
| Yunnan Yao Ke Yuan Biopharmaceuticals Co., Ltd. romanized | 国药准字H20255789 | 10ml:0.1g | Category B | XR03DAD179B002010184308 | NHSA |
| Hubei Wu Shi Pharmaceuticals Research Institute Co., Ltd. romanized | 国药准字H20253668 | 10ml:0.1g | Category B | XR03DAD179B002010184568 | NHSA |
| Kai Feng Ming Ren Pharma Co., Ltd. romanized | 国药准字H20244712 | 10ml:0.1g | Category B | XR03DAD179B002010184652 | NHSA |
| Henan Pu Rui Pharma Co., Ltd. romanized | 国药准字H20265518 | 10ml:0.1g | Category B | XR03DAD179B002010184683 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H20183214 | 10ml:0.1g | Category B | XR03DAD179B002010201066 | NHSA |
| Changzhou Lan Ling Pharmaceutical Co., Ltd. romanized | 国药准字H20103810 | 10ml:0.1g | Category B | XR03DAD179B002010201376 | NHSA |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H20203304 | 10ml:0.1g | Category B | XR03DAD179B002010201748 | NHSA |
| Sichuan Yi Sheng Zhi Tong Pharmaceuticals Bio Technology Development Co., Ltd. romanized | 国药准字H20213992 | 10ml:0.1g | Category B | XR03DAD179B002010202087 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203015 | 10ml:0.1g | Category B | XR03DAD179B002010202763 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20223300 | 10ml:0.1g | Category B | XR03DAD179B002010202770 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20213877 | 10ml:0.1g | Category B | XR03DAD179B002010202829 | NHSA |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223911 | 10ml:0.1g | Category B | XR03DAD179B002010203516 | NHSA |
| Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | 国药准字H20000304 | 10ml:0.1g | Category B | XR03DAD179B002010203731 | NHSA |
| Chi Feng Wan Ze Pharma Co., Ltd. romanized | 国药准字H20243638 | 10ml:0.1g | Category B | XR03DAD179B002010203869 | NHSA |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | 国药准字H20243777 | 10ml:0.1g | Category B | XR03DAD179B002010204131 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20233433 | 10ml:0.1g | Category B | XR03DAD179B002010204145 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183013 | 10ml:0.1g | Category B | XR03DAD179B002010204152 | NHSA |
| Fu An Pharma Group Yan Tai Zhi Chu Pharma Co., Ltd. romanized | 国药准字H20213990 | 10ml:0.1g | Category B | XR03DAD179B002010204251 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20243015 | 10ml:0.1g | Category B | XR03DAD179B002010204383 | NHSA |
| Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20041759 | 10ml:0.1g | Category B | XR03DAD179B002010204561 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20253360 | 10ml:0.1g | Category B | XR03DAD179B002010204606 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20040617 | 10ml:0.1g | Category B | XR03DAD179B002010204610 | NHSA |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20193088 | 10ml:0.1g | Category B | XR03DAD179B002010204646 | NHSA |
| Wei Sheng Yuan (Xiamen) Bio Technology Co., Ltd. romanized | 国药准字H20213430 | 10ml:0.1g | Category B | XR03DAD179B002010204827 | NHSA |
| Zhejiang Hai Han Pharma Co., Ltd. romanized | 国药准字H20213518 | 10ml:0.1g | Category B | XR03DAD179B002010206286 | NHSA |
| Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized | 国药准字H20183230 | 10ml:0.1g | Category B | XR03DAD179B002010206725 | NHSA |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20123351 | 10ml:0.1g | Category B | XR03DAD179B002010207478 | NHSA |
| Jilin Zhen Ao Pharmaceutical Co., Ltd. romanized | 国药准字H20233215 | 10ml:0.1g | Category B | XR03DAD179B002010209876 | NHSA |
| ABC Farmaceutici SPA | 国药准字HJ20170323 | 10ml:0.1g | Category B | XR03DAD179B002010279568 | NHSA |
| Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | 国药准字H20183135 | 10ml:0.1g | Category B | XR03DAD179B002010281128 | NHSA |
| Beijing Bai Mei Te Biopharmaceutical Co., Ltd. romanized | 国药准字H20223521 | 10ml:0.1g | Category B | XR03DAD179B002010282359 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20244080 | 10ml:0.1g | Category B | XR03DAD179B002010282474 | NHSA |
| Guangxi Ming Lei Wei Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20223695 | 10ml:0.1g | Category B | XR03DAD179B002010282886 | NHSA |
| Hebei Kai Wei Heng Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H20243618 | 10ml:0.1g | Category B | XR03DAD179B002010283007 | NHSA |
| Shandong Hua Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20223865 | 10ml:0.1g | Category B | XR03DAD179B002010283083 | NHSA |
| Kang Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20233192 | 10ml:0.1g | Category B | XR03DAD179B002010283596 | NHSA |
| Yunnan Yao Ke Yuan Biopharmaceuticals Co., Ltd. romanized | 国药准字H20255789 | 10ml:0.1g | Category B | XR03DAD179B002010284308 | NHSA |
| Kai Feng Ming Ren Pharma Co., Ltd. romanized | 国药准字H20244712 | 10ml:0.1g | Category B | XR03DAD179B002010284652 | NHSA |
| Henan Pu Rui Pharma Co., Ltd. romanized | 国药准字H20265518 | 10ml:0.1g | Category B | XR03DAD179B002010284683 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20213877 | 10ml:0.1g | Category B | XR03DAD179B002010302829 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20233433 | 10ml:0.1g | Category B | XR03DAD179B002010304145 | NHSA |
| Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | 国药准字H20243015 | 10ml:0.1g | Category B | XR03DAD179B002010304383 | NHSA |
| Name not romanized | 国药准字H20234452 | 10ml:0.1g | Category B | XR03DAD179B002010304610 | NHSA |
| Zhejiang Hai Han Pharma Co., Ltd. romanized | 国药准字H20213518 | 10ml:0.1g | Category B | XR03DAD179B002010306286 | NHSA |
| Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized | 国药准字H20183230 | 10ml:0.1g | Category B | XR03DAD179B002010306725 | NHSA |
| Jilin Zhen Ao Pharmaceutical Co., Ltd. romanized | 国药准字H20233215 | 10ml:0.1g | Category B | XR03DAD179B002010309876 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20244080 | 10ml:0.1g | Category B | XR03DAD179B002010382474 | NHSA |
| Shandong Hua Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20223865 | 10ml:0.1g | Category B | XR03DAD179B002010383083 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203015 | 10ml:0.1g | Category B | XR03DAD179B002010402763 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20213877 | 10ml:0.1g | Category B | XR03DAD179B002010402829 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20233433 | 10ml:0.1g | Category B | XR03DAD179B002010404145 | NHSA |
| Name not romanized | 国药准字H20234452 | 10ml:0.1g | Category B | XR03DAD179B002010404610 | NHSA |
| Kang Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20233192 | 10ml:0.1g | Category B | XR03DAD179B002010483596 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20233433 | 10ml:0.1g | Category B | XR03DAD179B002010504145 | NHSA |
| Shandong Qidu Pharmaceutical Co., Ltd. | 国药准字H20233433 | 10ml:0.1g | Category B | XR03DAD179B002010604145 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H20183215 | 10ml:0.2g | Category B | XR03DAD179B002020101066 | NHSA |
| Yang Zi Jiang Pharma Group Nanjing Hai Ling Pharma Co., Ltd. romanized | 国药准字H20203304 | 10ml:0.1g | Category B | XR03DAD179B002020101748 | NHSA |
| Sichuan Yi Sheng Zhi Tong Pharmaceuticals Bio Technology Development Co., Ltd. romanized | 国药准字H20223576 | 20ml:0.2g | Category B | XR03DAD179B002020102087 | NHSA |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20244561 | 10ml:0.1g | Category B | XR03DAD179B002020102357 | NHSA |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20269032 | 20ml:0.2g | Category B | XR03DAD179B002020103516 | NHSA |
| Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | 国药准字H20083883 | 20ml:0.2g | Category B | XR03DAD179B002020103731 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183014 | 10ml:0.2g | Category B | XR03DAD179B002020104152 | NHSA |
| Hainan Wei Kang Pharmaceutical (Qian Shan) Co., Ltd. romanized | 国药准字H20143050 | 20ml:0.3g | Category B | XR03DAD179B002020104384 | NHSA |
| Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20174093 | 10ml:0.2g | Category B | XR03DAD179B002020104561 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20133217 | 20ml:0.2g | Category B | XR03DAD179B002020104610 | NHSA |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20227105 | 20ml:0.2g | Category B | XR03DAD179B002020104646 | NHSA |
| Shanxi Nuo Cheng Pharmaceutical Co., Ltd. romanized | 国药准字H20183188 | 10ml:0.1g | Category B | XR03DAD179B002020105619 | NHSA |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20123350 | 20ml:0.3g | Category B | XR03DAD179B002020107478 | NHSA |
| Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | 国药准字H20183137 | 10ml:0.2g | Category B | XR03DAD179B002020181128 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20244081 | 20ml:0.2g | Category B | XR03DAD179B002020182474 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H20183215 | 10ml:0.2g | Category B | XR03DAD179B002020201066 | NHSA |
| Sichuan Yi Sheng Zhi Tong Pharmaceuticals Bio Technology Development Co., Ltd. romanized | 国药准字H20223576 | 20ml:0.2g | Category B | XR03DAD179B002020202087 | NHSA |
| Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | 国药准字H20083883 | 20ml:0.2g | Category B | XR03DAD179B002020203731 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183014 | 10ml:0.2g | Category B | XR03DAD179B002020204152 | NHSA |
| Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | 国药准字H20174093 | 10ml:0.2g | Category B | XR03DAD179B002020204561 | NHSA |
| Zhejiang Hua Yuan Pharma Co., Ltd. romanized | 国药准字H20227105 | 20ml:0.2g | Category B | XR03DAD179B002020204646 | NHSA |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20123350 | 20ml:0.3g | Category B | XR03DAD179B002020207478 | NHSA |
| Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | 国药准字H20183137 | 10ml:0.2g | Category B | XR03DAD179B002020281128 | NHSA |
| Hubei Mei Lin Pharma Co., Ltd. romanized | 国药准字H20244081 | 20ml:0.2g | Category B | XR03DAD179B002020282474 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183014 | 10ml:0.2g | Category B | XR03DAD179B002020304152 | NHSA |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20244562 | 20ml:0.2g | Category B | XR03DAD179B002030102357 | NHSA |
| Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | 国药准字H20083758 | 20ml:0.3g | Category B | XR03DAD179B002030103731 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183015 | 20ml:0.3g | Category B | XR03DAD179B002030104152 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20113407 | 20ml:0.3g | Category B | XR03DAD179B002030104610 | NHSA |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20143182 | 10ml:0.2g | Category B | XR03DAD179B002030107478 | NHSA |
| Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | 国药准字H20183136 | 20ml:0.3g | Category B | XR03DAD179B002030181128 | NHSA |
| Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | 国药准字H20244562 | 20ml:0.2g | Category B | XR03DAD179B002030202357 | NHSA |
| Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | 国药准字H20083758 | 20ml:0.3g | Category B | XR03DAD179B002030203731 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183015 | 20ml:0.3g | Category B | XR03DAD179B002030204152 | NHSA |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20143182 | 10ml:0.2g | Category B | XR03DAD179B002030207478 | NHSA |
| Shanxi Guo Run Pharmaceutical Co., Ltd. romanized | 国药准字H20183136 | 20ml:0.3g | Category B | XR03DAD179B002030281128 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183015 | 20ml:0.3g | Category B | XR03DAD179B002030304152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20183015 | 20ml:0.3g | Category B | XR03DAD179B002030404152 | NHSA |
| Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | 国药准字H20113407 | 20ml:0.3g | Category B | XR03DAD179B002040104610 | NHSA |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20217134 | 20ml:0.2g | Category B | XR03DAD179B002040107478 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20133217 | 20ml:0.2g | Category B | XR03DAD179B002040204610 | NHSA |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized | 国药准字H20133217 | 20ml:0.2g | Category B | XR03DAD179B002040304610 | NHSA |
| Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | 国药准字H20217134 | 20ml:0.2g | Category B | XR03DAD179B002050107478 | NHSA |
| Tong Hua Gu Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20269032 | 20ml:0.2g | Category B | XR03DAD179B002020203516 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 5 filings and 5 distinct first applicants.
Generic 4 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hubei Jin Yao Pharma Co., Ltd. romanized | CYHS2602174 | Generic | 2026/09/01 | Not stated by source | CDE |
| Xin He Yuan Sheng Pharmaceutical Co., Ltd. romanized | CYHS2601660 | Generic | 2026/07/13 | Not stated by source | CDE |
| Anhui Shuang He Pharma Co., Ltd. romanized | CYHS2504015 | Generic | 2025/11/20 | Not stated by source | CDE |
| Ge Lin Fei Er De (Jiangsu) Pharma Co., Ltd. romanized; Yue Kang Pharma Group Co., Ltd. romanized | CYHS2201234 | Generic | 2022/08/04 | Not stated by source | CDE |
| Guangxi Ming Lei Wei Sheng Pharmaceutical Co., Ltd. romanized | CYHB2601943 | Supplement | 2026/10/23 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hubei Jin Yao Pharma Co., Ltd. romanized | CYHS2602174 | Generic | 2026/09/01 | Not stated by source | CDE |
| Xin He Yuan Sheng Pharmaceutical Co., Ltd. romanized | CYHS2601660 | Generic | 2026/07/13 | Not stated by source | CDE |
API registrations
Non-component matches: 23 companies with A status and 4 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 多索茶碱 · No verified English name | Sichuan Yi Nuo Da Bo Pharmaceuticals Technology Co., Ltd. romanized | Y20250000769 | I | Exact ingredient | 2025/08/19 | CDE |
| 多索茶碱 · No verified English name | Bai Yun Shandong Tai Shang Qiu Pharma Co., Ltd. romanized | Y20250000283 | I | Exact ingredient | 2025/04/30 | CDE |
| 多索茶碱 · No verified English name | Hubei Wu Shi Pharma Co., Ltd. romanized | Y20230001361 | A | Exact ingredient | 2026/09/10 | CDE |
| 多索茶碱 · No verified English name | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20230000425 | A | Exact ingredient | 2026/07/03 | CDE |
| 多索茶碱 · No verified English name | Henan Sheng Lian Yi Pharmaceutical Co., Ltd. romanized | Y20230000052 | A | Exact ingredient | 2025/07/05 | CDE |
| 多索茶碱 · No verified English name | Zhejiang Yong Ning Pharma Co., Ltd. romanized | Y20220000979 | A | Exact ingredient | 2024/07/30 | CDE |
| 多索茶碱 · No verified English name | Chengdu Bai Yu Pharmaceutical Co., Ltd. romanized | Y20210001237 | A | Exact ingredient | 2025/12/31 | CDE |
| 多索茶碱 · No verified English name | Guo Yao Group Guo Rui Pharma Co., Ltd. romanized | Y20210001212 | A | Exact ingredient | 2024/01/20 | CDE |
| 多索茶碱 · No verified English name | Hebei Guang Xiang Pharmaceutical Co., Ltd. romanized | Y20210000927 | A | Exact ingredient | 2026/07/25 | CDE |
| 多索茶碱 · No verified English name | Chi Feng Wan Ze Pharma Co., Ltd. romanized | Y20210001004 | A | Exact ingredient | 2025/05/15 | CDE |
| 多索茶碱 · No verified English name | Hubei Mei Lin Pharma Co., Ltd. romanized | Y20210000516 | A | Exact ingredient | 2023/04/18 | CDE |
| 多索茶碱 · No verified English name | Shandong Lukang Pharmaceutical Co.,Ltd. | Y20210000238 | A | Exact ingredient | 2023/09/07 | CDE |
| 多索茶碱 · No verified English name | Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized | Y20200000718 | A | Exact ingredient | 2023/03/24 | CDE |
| 多索茶碱 · No verified English name | Yang Zi Jiang Pharma Group Jiangsu Hai Ci Bio Pharma Co., Ltd. romanized | Y20200000750 | A | Exact ingredient | 2026/10/31 | CDE |
| 多索茶碱 · No verified English name | Shandong Fang Ming Pharma Group Co., Ltd. romanized | Y20200000471 | A | Exact ingredient | 2025/11/01 | CDE |
| 多索茶碱 · No verified English name | Shi Yao Innovation Pharmaceutical Co., Ltd. romanized | Y20190001151 | A | Exact ingredient | 2024/01/17 | CDE |
| 多索茶碱 · No verified English name | Delta Finochem Private Limited | Y20190001108 | I | Exact ingredient | 2019/11/10 | CDE |
| 多索茶碱 · No verified English name | Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | Y20190009492 | A | Exact ingredient | 2025/05/15 | CDE |
| 多索茶碱 · No verified English name | Heilongjiang Fu He Pharmaceutical Group Co., Ltd. romanized | Y20190008493 | A | Exact ingredient | 2026/04/29 | CDE |
| 多索茶碱 · No verified English name | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Y20190007315 | A | Exact ingredient | 2023/10/08 | CDE |
| 多索茶碱 · No verified English name | Zhejiang Chang Ming Pharma Co., Ltd. romanized | Y20190001752 | A | Exact ingredient | 2025/05/30 | CDE |
| 多索茶碱 · No verified English name | Cohance Lifesciences Limited | Y20190000458 | A | Exact ingredient | 2026/01/17 | CDE |
| 多索茶碱 · No verified English name | Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | Y20190000170 | I | Exact ingredient | 2019/03/26 | CDE |
| 多索茶碱 · No verified English name | Ami Lifesciences Pvt. Ltd. | Y20170001857 | A | Exact ingredient | 2023/07/28 | CDE |
| 多索茶碱 · No verified English name | Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | Y20170001388 | A | Exact ingredient | 2025/11/22 | CDE |
| 多索茶碱 · No verified English name | Anhui Heng Xing Pharmaceutical Co., Ltd. romanized | Y20170001273 | A | Exact ingredient | 2023/12/13 | CDE |
| 多索茶碱 · No verified English name | Liaoning Yao Lian Pharmaceutical Co., Ltd. romanized | Y20170000856 | A | Exact ingredient | 2024/01/10 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/10/23Accepted
Guangxi Ming Lei Wei Sheng Pharmaceutical Co., Ltd. romanized
CYHB2601943
Fact date: 2026/10/23 · Site observation date: 2026/10/24
View source ↗ -
2026/09/01Accepted
Hubei Jin Yao Pharma Co., Ltd. romanized
CYHS2602174
Fact date: 2026/09/01 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Doxofylline Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy